{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:23:18Z","timestamp":1780582998014,"version":"3.54.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.semarthrit.2007.04.002","type":"journal-article","created":{"date-parts":[[2007,6,21]],"date-time":"2007-06-21T11:08:39Z","timestamp":1182424119000},"page":"189-197","source":"Crossref","is-referenced-by-count":109,"title":["Anakinra in Patients with Treatment-Resistant Adult-Onset Still\u2019s Disease: Four Case Reports with Serial Cytokine Measurements and a Review of the Literature"],"prefix":"10.1016","volume":"37","author":[{"given":"Ina","family":"K\u00f6tter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Wacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Henes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanze","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilhan","family":"G\u00fcnaydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"Kanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.semarthrit.2007.04.002_bib1","first-page":"424","article-title":"Preliminary criteria for classification of adult Still\u2019s disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2007.04.002_bib2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","article-title":"Adult Still\u2019s disease: manifestations, disease course, and outcome in 62 patients","volume":"70","author":"Pouchot","year":"1991","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.semarthrit.2007.04.002_bib3","first-page":"1139","article-title":"Adult Still\u2019s disease: review of 228 cases from the literature","volume":"14","author":"Ohta","year":"1987","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2007.04.002_bib4","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/art.11368","article-title":"Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review","volume":"49","author":"Dhote","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2007.04.002_bib5","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/art.21061","article-title":"Rapid responses to anakinra in patients with refractory adult-onset Still\u2019s disease","volume":"52","author":"Fitzgerald","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2007.04.002_bib6","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/art.10870","article-title":"Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra) in patients with rheumatoid arthritis: a large, international, multicenter, placebo-controlled trial","volume":"48","author":"Fleischmann","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2007.04.002_bib7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/01.rhu.0000089966.48691.7f","article-title":"Successful treatment of a patient with refractory adult-onset Still disease with anakinra","volume":"9","author":"Rudinskaya","year":"2003","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2007.04.002_bib8","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/ard.2004.026617","article-title":"Refractory adult onset Still\u2019s disease successfully treated with anakinra","volume":"64","author":"Vasques Godinho","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2007.04.002_bib9","first-page":"2071","article-title":"Effective use of the recombinant interleukin 1 receptor antagonist anakinra in hterapy resistant systemic onset juvenile rheumatoid arthritis","volume":"31","author":"Verbsky","year":"2004","journal-title":"J Rheumatol"},{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2007.04.002_bib10","first-page":"265","article-title":"Prompt response to treatment with anakinra in adult onset Still\u2018s disease","volume":"63","author":"Aelion","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2007.04.002_bib11","first-page":"263","article-title":"Anakinra in the treatment of adult onset Still\u2018s disease","volume":"63","author":"Haraoui","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"99","key":"10.1016\/j.semarthrit.2007.04.002_bib12","first-page":"377","article-title":"The rash of rheumatoid arthritis and Still\u2019s disease","volume":"25","author":"Bywaters","year":"1956","journal-title":"Q J Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2007.04.002_bib13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.semarthrit.2006.07.001","article-title":"Pathogenesis and management of adult-onset Still\u2019s disease","volume":"36","author":"Efthimiou","year":"2006","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2007.04.002_bib14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.berh.2004.05.004","article-title":"Adult-onset Still\u2019s disease","volume":"18","author":"Kadar","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2007.04.002_bib15","first-page":"373","article-title":"Corticosteroid sparing effect of low dose methotrexate treatment in adult Still\u2019s disease","volume":"26","author":"Fautrel","year":"1999","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2007.04.002_bib16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/ard.56.2.144","article-title":"Methotrexate treatment in patients with adult onset Still\u2019s disease\u2014retrospective study of 13 Japanese cases","volume":"56","author":"Fujii","year":"1997","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2007.04.002_bib17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/BF01451061","article-title":"Successful methotrexate therapy for adult Still\u2019s disease with marked thrombocytopenia","volume":"17","author":"Yamaguchi","year":"1998","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2007.04.002_bib18","first-page":"431","article-title":"Low dose methotrexate treatment in adult Still\u2019s disease","volume":"19","author":"Aydintug","year":"1992","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2007.04.002_bib19","first-page":"918","article-title":"Fever in adult onset Still\u2019s disease","volume":"18","author":"Kraus","year":"1991","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2007.04.002_bib20","first-page":"245","article-title":"High toxicity of sulfasalazine in adult-onset Still\u2019s disease","volume":"18","author":"Jung","year":"2000","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2007.04.002_bib21","first-page":"2067","article-title":"Intravenous immunoglobulin in the treatment of refractory adult Still\u2019s disease","volume":"26","author":"Mahmud","year":"1999","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2007.04.002_bib22","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/rheumatology\/38.10.1024","article-title":"Intravenous immunoglobulins for adult Still\u2019s disease and pregnancy","volume":"38","author":"Liozon","year":"1999","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.semarthrit.2007.04.002_bib23","first-page":"295","article-title":"Intravenous immunoglobulin in adult Still\u2019s disease refractory to non-steroidal anti-inflammatory drugs","volume":"16","author":"Vignes","year":"1998","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2007.04.002_bib24","first-page":"797","article-title":"Intravenous immunoglobulins in Still\u2019s disease: still controversial, still unproven","volume":"23","author":"Prieur","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2007.04.002_bib25","doi-asserted-by":"crossref","unstructured":"Kulke R, Koeppel M, Hey D. Treatment of adult Still\u2019s disease with intravenous immunoglobulin. Lancet 337;347(8997):337.","DOI":"10.1016\/S0140-6736(96)90521-8"},{"issue":"4","key":"10.1016\/j.semarthrit.2007.04.002_bib26","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1345\/aph.1E425","article-title":"Leflunomide and azathioprine combination in refractory adult-onset Still\u2019s disease","volume":"39","author":"Cefle","year":"2005","journal-title":"Ann Pharmacother"},{"issue":"7","key":"10.1016\/j.semarthrit.2007.04.002_bib27","first-page":"1391","article-title":"Cyclosporin A in the treatment of adult Still\u2019s disease","volume":"22","author":"Shojania","year":"1995","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2007.04.002_bib28","first-page":"1582","article-title":"Cyclosporin A in the treatment of adult onset Still\u2019s disease","volume":"24","author":"Marchesoni","year":"1997","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2007.04.002_bib29","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00000441-200309000-00009","article-title":"Successful treatment with cyclosporin in adult-onset Still disease manifesting as acute hepatitis with marked hyperferritinemia","volume":"326","author":"Omagari","year":"2003","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1016\/j.semarthrit.2007.04.002_bib30","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/ard.2004.024026","article-title":"Tumour necrosis factor alpha blocking agents in refractory adult Still\u2019s disease: an observational study of 20 cases","volume":"64","author":"Fautrel","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2007.04.002_bib31","first-page":"121","article-title":"Prolonged efficacy of infliximab for refractory adult-onset Still\u2019s disease","volume":"23","author":"Dilhuydy","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2007.04.002_bib32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10067-003-0775-5","article-title":"Successful treatment of refractory adult-onset Still\u2019s disease with infliximab","volume":"23","author":"Kokkinos","year":"2004","journal-title":"Clin Rheumatol"},{"issue":"4-5","key":"10.1016\/j.semarthrit.2007.04.002_bib33","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10067-003-0744-z","article-title":"Infliximab in a case of early adult-onset Still\u2019s disease","volume":"22","author":"Olivieri","year":"2003","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2007.04.002_bib34","unstructured":"Caramaschi P, Biasi D, Carletto A, Bambara LM. A case of adult onset Still\u2019s disease treated with infliximab. Clin Exp Rheumatol 113;20(1):113."},{"issue":"Suppl 3","key":"10.1016\/j.semarthrit.2007.04.002_bib35","doi-asserted-by":"crossref","first-page":"iii55","DOI":"10.1136\/ard.60.90003.iii55","article-title":"Successful treatment of a small cohort of patients with adult onset of Still\u2019s disease with infliximab: first experiences","volume":"60","author":"Kraetsch","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2007.04.002_bib36","first-page":"329","article-title":"Infliximab in the treatment of adult Still\u2019s disease refractory to conventional therapy","volume":"19","author":"Cavagna","year":"2001","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2007.04.002_bib37","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10067-004-1064-7","article-title":"Prolonged remission in adult-onset Still\u2019s disease with etanercept","volume":"25","author":"Kumari","year":"2006","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2007.04.002_bib38","first-page":"653","article-title":"The medical uses and side effects of etanercept with a focus on cutaneous disease","volume":"3","author":"Scheinfeld","year":"2004","journal-title":"J Drugs Dermatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2007.04.002_bib39","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.amjmed.2003.04.001","article-title":"Resolution with etanercept of nephrotic syndrome due to renal AA amyloidosis in adult Still\u2019s disease","volume":"115","author":"Serratrice","year":"2003","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.semarthrit.2007.04.002_bib40","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/art.10231","article-title":"Etanercept in the treatment of adult patients with Still\u2019s disease","volume":"46","author":"Husni","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.semarthrit.2007.04.002_bib41","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1002\/art.10620","article-title":"Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still\u2019s disease","volume":"46","author":"Iwamoto","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.semarthrit.2007.04.002_bib42","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/sj.bmt.1702435","article-title":"Prolonged remission state of refractory adult onset Still\u2019s disease following CD34-selected autologous peripheral blood stem cell transplantation","volume":"25","author":"Lanza","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"29-30","key":"10.1016\/j.semarthrit.2007.04.002_bib43","first-page":"414","article-title":"Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders","volume":"132","author":"Aeberli","year":"2002","journal-title":"Swiss Med Wkly"},{"issue":"7","key":"10.1016\/j.semarthrit.2007.04.002_bib44","first-page":"1624","article-title":"Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset still\u2019s disease","volume":"30","author":"Michel","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2007.04.002_bib45","unstructured":"La Montagna G, Valentini G. Listeria monocytogenes meningitis in a patient receiving etanercept for Still\u2019s disease. Clin Exp Rheumatol 121;23(1):121."},{"issue":"3","key":"10.1016\/j.semarthrit.2007.04.002_bib46","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/art.21164","article-title":"Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still\u2019s disease","volume":"53","author":"Chen","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.semarthrit.2007.04.002_bib47","first-page":"2189","article-title":"Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still\u2019s disease","volume":"31","author":"Chen","year":"2004","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2007.04.002_bib48","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.clim.2004.03.023","article-title":"Adult Still\u2019s disease reflects a Th2 rather than a Th1 cytokine profile","volume":"112","author":"Saiki","year":"2004","journal-title":"Clin Immunol"},{"issue":"11","key":"10.1016\/j.semarthrit.2007.04.002_bib49","first-page":"2422","article-title":"Serum cytokine profiles in patients with adult onset Still\u2019s disease","volume":"30","author":"Choi","year":"2003","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2007.04.002_bib50","first-page":"1093","article-title":"Interleukin 18 and hepatocyte growth factor in fulminant hepatic failure of adult onset Still\u2019s disease","volume":"30","author":"Ogata","year":"2003","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.semarthrit.2007.04.002_bib51","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/rheumatology\/40.12.1398","article-title":"Cytokine and immunogenetic profiles in Japanese patients with adult Still\u2019s disease","volume":"40","author":"Fujii","year":"2001","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.semarthrit.2007.04.002_bib52","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/1529-0131(200103)44:3<550::AID-ANR103>3.0.CO;2-5","article-title":"Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still\u2019s disease","volume":"44","author":"Kawashima","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2007.04.002_bib53","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095","article-title":"Biologic basis for interleukin-1 in disease","volume":"87","author":"Dinarello","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2007.04.002_bib54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1749-6632.1998.tb08310.x","article-title":"IL-6 nd IL-1\u03b2 in fever; studies using cytokine-deficient (knockout) mice","volume":"856","author":"Kozak","year":"1998","journal-title":"Ann NY Acad Sci"},{"issue":"Suppl II","key":"10.1016\/j.semarthrit.2007.04.002_bib55","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/ard.62.suppl_2.ii48","article-title":"Role of interleukin 18 in Rheumatoid Arthritis","volume":"62","author":"Liew","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2007.04.002_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1020506300324","article-title":"Interleukin-18 and Interleukin-1\u03b2: two cytokine substrates for ICE (caspase 1)","volume":"19","author":"Fantuzzi","year":"1999","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.semarthrit.2007.04.002_bib57","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/art.20268","article-title":"Increased interleukin-18 expression in bone marrow of a patient with systemic juvenile idiopathic arthritis and unrecognized macrophage-activation syndrome","volume":"50","author":"Maeno","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.semarthrit.2007.04.002_bib58","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1136\/ard.2005.046904","article-title":"Reactive haemophagocytic syndrome in adult-onset Still\u2019s disease: a report of six patients and a review of the literature","volume":"65","author":"Arlet","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2007.04.002_bib59","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000083450","article-title":"Macrophage activation syndrome in children with systemic-onset juvenile chronic arthritis","volume":"113","author":"Kounami","year":"2005","journal-title":"Acta Haematol"},{"issue":"2","key":"10.1016\/j.semarthrit.2007.04.002_bib60","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1568-9972(03)00091-0","article-title":"Pathogenesis of hemophagocytic syndrome (HPS)","volume":"3","author":"Larroche","year":"2004","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.semarthrit.2007.04.002_bib61","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1386-6346(99)00071-6","article-title":"Adult onset Still\u2019s disease with hemophagocytic syndrome and severe liver dysfunction","volume":"17","author":"Takeshita","year":"2000","journal-title":"Hepatol Res"},{"issue":"7","key":"10.1016\/j.semarthrit.2007.04.002_bib62","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/sj.gene.6363922","article-title":"Association between adult-onset Still\u2019s disease and interleukin-18 gene polymorphisms","volume":"3","author":"Sugiura","year":"2002","journal-title":"Genes Immun"},{"key":"10.1016\/j.semarthrit.2007.04.002_bib63","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1172\/JCI1379","article-title":"Interleukin-18 (IFN-g inducing factor) induces IL-1\u03b2 and IL-8 via TNF-a production from non CD14+ human blood mononuclear cells","volume":"101","author":"Puren","year":"1998","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.semarthrit.2007.04.002_bib64","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/art.20268","article-title":"Increased interleukin-18 expression in bone marrow of a patient with systemic juvenile idiopathic arthritis and unrecognized macrophage-activation syndrome","volume":"50","author":"Maeno","year":"2004","journal-title":"Arthritis Rheum"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017207000741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017207000741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T11:22:52Z","timestamp":1737112972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017207000741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0049017207000741"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2007.04.002","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}